<p>(A) Schedule of prime-boost-challenge vaccinations. Mice were primed intramuscularly on Day 0 and 6. 35 days later the mice were boosted. Mice were challenged intraperitoneally 33 days post prime. PBS mice were included as a negative control. 5 days after challenge, mice were euthanized and spleens harvested for analysis of the cellular response. (B–D) Each point is representative of splenocytes from one mouse (n = 5 per group). (B) The quantity of activated HIV-1 Gag-specific CD8<sup>+</sup> T cells in the spleen was analyzed by flow cytometry and the percentage of cells are shown. Activated cells were determined by gating on CD62L<sup>lo</sup> cells and HIV-1 Gag-specific cells were determined by tetramer staining against the H2<sup>d<...
<p>(<b>A</b>) Description of the different vectors employed in the DNA/MVA immunization schemes appl...
<p>(A) groups of 3 (young) and 12 (old) month old mice were primed with 10<sup>5</sup> PFU of MCMV, ...
<p>WT BALB/c and IL-13 KO mice (n = 4–5/ group) were prime-boost immunized with i.n. FPV-HIV/ i.m. V...
<p>(A) Schedule of prime-boost-challenge vaccinations. Mice were primed intramuscularly. 35 days lat...
<p>(A) Schedule of prime-boost vaccinations. Mice were primed intramuscularly on Day 0 and 6. 35 day...
<p>(A) Schedule of prime-boost vaccinations. Mice were primed intramuscularly. 35 days later the mic...
<p>(<b>A</b>) Vaccination schedule used. (<b>B</b>) Cumulative IFN-γ ELISPOT CD8<sup>+</sup> and CD4...
<p>(A) Magnitude of the vaccine-specific CD4 or CD8 T cell responses. The HIV-specific CD4 or CD8 T ...
<p>Mice were injected i.m. on days 1 and 21 with 50 µg of the indicated pITR plasmids encoding mouse...
<p>(A-B) TCR-V cells were adoptively transferred into B6 mice one day prior to infection with cognat...
<p>(A) Magnitude of the vaccine-specific CD4 or CD8 T cell response. The HIV-specific CD4 or CD8 T c...
<p>Balb/c mice (5–6/group) were immunized with 1×10<sup>8</sup> pfu of Ad vector (Ad-CMV-gagopt, Ad-...
<p>Mice were vaccinated i.n. with FPV-HIV and/or i.m. VV-HIV. Mice were vaccinated with 5×10<sup>6</...
<p>Mice were vaccinated with 24 different vaccine regimes based on all combinations of FPV-HIV and V...
<p>Filovirus specific cellular immune response was detected by ELISPOT after stimulation with peptid...
<p>(<b>A</b>) Description of the different vectors employed in the DNA/MVA immunization schemes appl...
<p>(A) groups of 3 (young) and 12 (old) month old mice were primed with 10<sup>5</sup> PFU of MCMV, ...
<p>WT BALB/c and IL-13 KO mice (n = 4–5/ group) were prime-boost immunized with i.n. FPV-HIV/ i.m. V...
<p>(A) Schedule of prime-boost-challenge vaccinations. Mice were primed intramuscularly. 35 days lat...
<p>(A) Schedule of prime-boost vaccinations. Mice were primed intramuscularly on Day 0 and 6. 35 day...
<p>(A) Schedule of prime-boost vaccinations. Mice were primed intramuscularly. 35 days later the mic...
<p>(<b>A</b>) Vaccination schedule used. (<b>B</b>) Cumulative IFN-γ ELISPOT CD8<sup>+</sup> and CD4...
<p>(A) Magnitude of the vaccine-specific CD4 or CD8 T cell responses. The HIV-specific CD4 or CD8 T ...
<p>Mice were injected i.m. on days 1 and 21 with 50 µg of the indicated pITR plasmids encoding mouse...
<p>(A-B) TCR-V cells were adoptively transferred into B6 mice one day prior to infection with cognat...
<p>(A) Magnitude of the vaccine-specific CD4 or CD8 T cell response. The HIV-specific CD4 or CD8 T c...
<p>Balb/c mice (5–6/group) were immunized with 1×10<sup>8</sup> pfu of Ad vector (Ad-CMV-gagopt, Ad-...
<p>Mice were vaccinated i.n. with FPV-HIV and/or i.m. VV-HIV. Mice were vaccinated with 5×10<sup>6</...
<p>Mice were vaccinated with 24 different vaccine regimes based on all combinations of FPV-HIV and V...
<p>Filovirus specific cellular immune response was detected by ELISPOT after stimulation with peptid...
<p>(<b>A</b>) Description of the different vectors employed in the DNA/MVA immunization schemes appl...
<p>(A) groups of 3 (young) and 12 (old) month old mice were primed with 10<sup>5</sup> PFU of MCMV, ...
<p>WT BALB/c and IL-13 KO mice (n = 4–5/ group) were prime-boost immunized with i.n. FPV-HIV/ i.m. V...